vs
FORUM ENERGY TECHNOLOGIES, INC.（FET）とOrthofix Medical Inc.（OFIX）の財務データ比較。上の社名をクリックして会社を切り替えられます
Orthofix Medical Inc.の直近四半期売上が大きい（$219.9M vs $202.2M、FORUM ENERGY TECHNOLOGIES, INC.の約1.1倍）。FORUM ENERGY TECHNOLOGIES, INC.の純利益率が高く（1.0% vs -1.0%、差は2.0%）。Orthofix Medical Inc.の前年同期比売上増加率が高い（2.0% vs 0.6%）。FORUM ENERGY TECHNOLOGIES, INC.の直近四半期フリーキャッシュフローが多い（$20.9M vs $16.8M）。過去8四半期でOrthofix Medical Inc.の売上複合成長率が高い（8.0% vs -0.0%）
Forum Energy Technologiesは米国に本拠を置くエネルギー分野の製品企業で、世界中の石油・ガス業界ならびに再生可能エネルギー業界に向け、関連製品と専門サービスを提供しています。
オーソフィックスメディカル社は世界的な整形外科医療機器メーカーで、脊椎インプラント、整形外科用外傷治療製品、骨成長刺激療法機器、再生医療製品の開発・製造・販売を事業としています。北米、欧州、アジア太平洋を中心に整形外科医や医療機関向けに製品を提供し、筋骨格系疾患患者の治療成績向上に取り組んでいます。
FET vs OFIX — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $202.2M | $219.9M |
| 純利益 | $2.1M | $-2.2M |
| 粗利率 | 30.2% | 71.1% |
| 営業利益率 | 6.3% | 0.2% |
| 純利益率 | 1.0% | -1.0% |
| 売上前年比 | 0.6% | 2.0% |
| 純利益前年比 | 102.0% | 92.4% |
| EPS（希薄化後） | $0.25 | $-0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $202.2M | $219.9M | ||
| Q3 25 | $196.2M | $205.6M | ||
| Q2 25 | $199.8M | $203.1M | ||
| Q1 25 | $193.3M | $193.6M | ||
| Q4 24 | $201.0M | $215.7M | ||
| Q3 24 | $207.8M | $196.6M | ||
| Q2 24 | $205.2M | $198.6M | ||
| Q1 24 | $202.4M | $188.6M |
| Q4 25 | $2.1M | $-2.2M | ||
| Q3 25 | $-20.6M | $-22.8M | ||
| Q2 25 | $7.7M | $-14.1M | ||
| Q1 25 | $1.1M | $-53.1M | ||
| Q4 24 | $-103.5M | $-29.1M | ||
| Q3 24 | $-14.8M | $-27.4M | ||
| Q2 24 | $-6.7M | $-33.4M | ||
| Q1 24 | $-10.3M | $-36.0M |
| Q4 25 | 30.2% | 71.1% | ||
| Q3 25 | 20.5% | 72.2% | ||
| Q2 25 | 29.7% | 68.7% | ||
| Q1 25 | 30.2% | 62.8% | ||
| Q4 24 | 31.1% | 69.0% | ||
| Q3 24 | 31.6% | 68.7% | ||
| Q2 24 | 30.7% | 67.8% | ||
| Q1 24 | 31.5% | 67.5% |
| Q4 25 | 6.3% | 0.2% | ||
| Q3 25 | -3.1% | -8.3% | ||
| Q2 25 | 7.4% | -7.9% | ||
| Q1 25 | 4.6% | -25.2% | ||
| Q4 24 | -53.1% | -5.3% | ||
| Q3 24 | 4.3% | -9.6% | ||
| Q2 24 | 3.9% | -12.5% | ||
| Q1 24 | 1.6% | -15.6% |
| Q4 25 | 1.0% | -1.0% | ||
| Q3 25 | -10.5% | -11.1% | ||
| Q2 25 | 3.9% | -6.9% | ||
| Q1 25 | 0.6% | -27.4% | ||
| Q4 24 | -51.5% | -13.5% | ||
| Q3 24 | -7.1% | -13.9% | ||
| Q2 24 | -3.3% | -16.8% | ||
| Q1 24 | -5.1% | -19.1% |
| Q4 25 | $0.25 | $-0.05 | ||
| Q3 25 | $-1.76 | $-0.57 | ||
| Q2 25 | $0.61 | $-0.36 | ||
| Q1 25 | $0.09 | $-1.35 | ||
| Q4 24 | $-8.41 | $-0.76 | ||
| Q3 24 | $-1.20 | $-0.71 | ||
| Q2 24 | $-0.54 | $-0.88 | ||
| Q1 24 | $-0.85 | $-0.95 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $34.7M | $82.0M |
| 総負債低いほど良い | $135.9M | — |
| 株主資本純資産 | $291.1M | $450.0M |
| 総資産 | $752.5M | $850.6M |
| 負債/資本比率低いほどレバレッジが低い | 0.47× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $34.7M | $82.0M | ||
| Q3 25 | $31.7M | $62.9M | ||
| Q2 25 | $39.0M | $65.6M | ||
| Q1 25 | $31.1M | $58.0M | ||
| Q4 24 | $44.7M | $83.2M | ||
| Q3 24 | $33.3M | $30.1M | ||
| Q2 24 | $31.8M | $26.4M | ||
| Q1 24 | $48.5M | $27.0M |
| Q4 25 | $135.9M | — | ||
| Q3 25 | $140.0M | $157.2M | ||
| Q2 25 | $159.3M | $157.0M | ||
| Q1 25 | $171.4M | $156.9M | ||
| Q4 24 | $188.4M | $157.0M | ||
| Q3 24 | $231.5M | $118.5M | ||
| Q2 24 | $252.9M | $118.0M | ||
| Q1 24 | $287.5M | $118.2M |
| Q4 25 | $291.1M | $450.0M | ||
| Q3 25 | $297.3M | $442.5M | ||
| Q2 25 | $334.2M | $458.3M | ||
| Q1 25 | $320.0M | $458.3M | ||
| Q4 24 | $319.9M | $503.1M | ||
| Q3 24 | $443.5M | $525.9M | ||
| Q2 24 | $442.0M | $546.0M | ||
| Q1 24 | $446.2M | $570.3M |
| Q4 25 | $752.5M | $850.6M | ||
| Q3 25 | $770.1M | $832.6M | ||
| Q2 25 | $810.1M | $837.2M | ||
| Q1 25 | $790.1M | $823.1M | ||
| Q4 24 | $816.0M | $893.3M | ||
| Q3 24 | $973.7M | $867.9M | ||
| Q2 24 | $976.8M | $882.0M | ||
| Q1 24 | $1.0B | $906.0M |
| Q4 25 | 0.47× | — | ||
| Q3 25 | 0.47× | 0.36× | ||
| Q2 25 | 0.48× | 0.34× | ||
| Q1 25 | 0.54× | 0.34× | ||
| Q4 24 | 0.59× | 0.31× | ||
| Q3 24 | 0.52× | 0.23× | ||
| Q2 24 | 0.57× | 0.22× | ||
| Q1 24 | 0.64× | 0.21× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $22.4M | $27.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $20.9M | $16.8M |
| FCFマージンFCF / 売上 | 10.3% | 7.6% |
| 設備投資強度設備投資 / 売上 | 0.8% | 4.9% |
| キャッシュ転換率営業CF / 純利益 | 10.83× | — |
| 直近12ヶ月FCF直近4四半期 | $64.4M | $-1.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $22.4M | $27.7M | ||
| Q3 25 | $22.9M | $12.4M | ||
| Q2 25 | $15.8M | $11.6M | ||
| Q1 25 | $9.3M | $-18.4M | ||
| Q4 24 | $38.5M | $23.7M | ||
| Q3 24 | $25.6M | $11.7M | ||
| Q2 24 | $23.1M | $9.0M | ||
| Q1 24 | $5.0M | $-18.6M |
| Q4 25 | $20.9M | $16.8M | ||
| Q3 25 | $21.5M | $2.5M | ||
| Q2 25 | $14.8M | $4.5M | ||
| Q1 25 | $7.2M | $-25.1M | ||
| Q4 24 | $36.1M | $15.2M | ||
| Q3 24 | $24.3M | $6.3M | ||
| Q2 24 | $21.6M | $-360.0K | ||
| Q1 24 | $2.1M | $-29.1M |
| Q4 25 | 10.3% | 7.6% | ||
| Q3 25 | 10.9% | 1.2% | ||
| Q2 25 | 7.4% | 2.2% | ||
| Q1 25 | 3.7% | -13.0% | ||
| Q4 24 | 18.0% | 7.0% | ||
| Q3 24 | 11.7% | 3.2% | ||
| Q2 24 | 10.5% | -0.2% | ||
| Q1 24 | 1.0% | -15.4% |
| Q4 25 | 0.8% | 4.9% | ||
| Q3 25 | 0.7% | 4.8% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 1.1% | 3.5% | ||
| Q4 24 | 1.2% | 4.0% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 0.7% | 4.7% | ||
| Q1 24 | 1.4% | 5.6% |
| Q4 25 | 10.83× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.05× | — | ||
| Q1 25 | 8.31× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FET
| Drilling And Completions Segment | $127.2M | 63% |
| Artificial Lift And Downhole Segment | $75.5M | 37% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
